Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,329 Cr
verified against source
Revenue YoY
—
reported change
EBITDA
₹124 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Galaxy Surfactants reported Q3 FY26 EBITDA of ₹124 crore, up 13% YoY, driven by strong specialty volume growth in India (+35%) and rest-of-world markets, partially offset by continued reformulation pressures from a key Indian tier-1 account and US tariff headwinds. EBITDA per metric ton improved to ₹20,156 from ₹17,527 last year, aided by cost efficiencies and a favorable mix shift toward high-margin prestige specialties. India performance actives declined ~4% due to reformulation, while the specialty segment grew >35%. The US reciprocal tariff reduction from 50% to 18% is a major structural positive, expected to revive pipeline projects from late Q4. However, fatty alcohol prices remain elevated, and the Egypt/AMET region saw high-teens volume decline due to competitive intensity. Management expects gradual recovery in India with new formulations commercializing in Q4, but near-term visibility remains limited. Key risk: sustained high fatty alcohol prices could prolong reformulation and delay volume recovery.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects double-digit volume growth in the specialty segment in India, supported by new product launches and customer approvals.
- Alternate formulations for key tier-1 customers are under approval and expected to start commercialization in Q4 FY26.
- With tariff reduction, customer projects put on hold are expected to resume, contributing from late Q4 FY26 and Q1 FY27.
- Management expects fatty alcohol prices to start correcting from May onwards due to seasonal palm production increases.
Risks flagged
- Fatty alcohol prices remain elevated, prolonging reformulation pressures and delaying volume recovery in India.
- Key US customers have flagged demand concerns in beauty and wellbeing, which could temper specialty volume recovery despite tariff relief.
- Management acknowledged that peak volumes in AMET are unlikely to return due to backward-integrated local competitors and currency depreciation in Egypt.
- The EPC project with a US customer provides only modest income and is not expected to materially impact earnings.
Key quotes
- If the first half was about resilience, our Q3 has been a quarter where multiple headwinds converged testing our agility, execution and resolve.
- We are confident that the worst is behind us with the India growth story improving, volume gradually recovering, incremental profitability expected from the recent US India tariff reduction announcement and a sustained improvement in our premium specialty product mix.
- I don't see that we'll be able to come back to the peak volumes [in AMET] very clearly.
Research modules